Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
01.05.24
/
50%
€12.59
Target price
01.05.25
€26.21
Performance (%)
-12.31%
Price
16.05.24
€11.04
Summary
This prediction is currently active. The prediction for Sage Therapeutics Inc. disappoints with a performance of -12.31%. This prediction currently runs until 01.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Sage Therapeutics Inc. | -0.090% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
26.03.24
26.03.24
€26.71
26.03.25
26.03.25
-37.62%
16.05.24
16.05.24